112 related articles for article (PubMed ID: 23435724)
1. Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.
Tsai C; Leslie JS; Franko-Tobin LG; Prasnal MC; Yang T; Vienna Mackey L; Fuselier JA; Coy DH; Liu M; Yu C; Sun L
Arch Gynecol Obstet; 2013 Aug; 288(2):393-400. PubMed ID: 23435724
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.
Sun L; Qian Q; Sun G; Mackey LV; Fuselier JA; Coy DH; Yu CY
J Drug Target; 2016; 24(2):169-77. PubMed ID: 26211366
[TBL] [Abstract][Full Text] [Related]
3. Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.
Franko-Tobin LG; Mackey LV; Huang W; Song X; Jin B; Luo J; Morris LM; Liu M; Fuselier JA; Coy DH; Wu L; Sun L
Oncologist; 2012; 17(2):220-32. PubMed ID: 22291092
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation.
Feng S; Yang Y; Lv J; Sun L; Liu M
Int J Oncol; 2016 Jul; 49(1):422-30. PubMed ID: 27176495
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.
Sun L; He Q; Tsai C; Lei J; Chen J; Vienna Makcey L; Coy DH
Am J Transl Res; 2018; 10(2):545-553. PubMed ID: 29511449
[TBL] [Abstract][Full Text] [Related]
7. Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.
Shabbeer S; Kortenhorst MS; Kachhap S; Galloway N; Rodriguez R; Carducci MA
Prostate; 2007 Jul; 67(10):1099-110. PubMed ID: 17477369
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.
Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q
J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
11. The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.
Sun G; Mackey LV; Coy DH; Yu CY; Sun L
J Cancer; 2015; 6(10):996-1004. PubMed ID: 26366213
[TBL] [Abstract][Full Text] [Related]
12. Combination of valproic acid and ATRA restores RARβ2 expression and induces differentiation in cervical cancer through the PI3K/Akt pathway.
Feng D; Cao Z; Li C; Zhang L; Zhou Y; Ma J; Liu R; Zhou H; Zhao W; Wei H; Ling B
Curr Mol Med; 2012 Mar; 12(3):342-54. PubMed ID: 22229477
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH
Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo.
Machado MC; Bellodi-Privato M; Kubrusly MS; Molan NA; Tharcisio T; de Oliveira ER; D'Albuquerque LA
J Exp Ther Oncol; 2011; 9(2):85-92. PubMed ID: 21699015
[TBL] [Abstract][Full Text] [Related]
15. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
Sharma K; Patel YC; Srikant CB
Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
18. Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.
Nagai H; Fujioka-Kobayashi M; Ohe G; Hara K; Takamaru N; Uchida D; Tamatani T; Fujisawa K; Miyamoto Y
Oncol Rep; 2014 Mar; 31(3):1453-8. PubMed ID: 24398788
[TBL] [Abstract][Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
20. Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo.
Shan Z; Feng-Nian R; Jie G; Ting Z
Asian Pac J Cancer Prev; 2012; 13(8):3977-82. PubMed ID: 23098503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
